The Innovative Medicines Initiative −10 Years of Public-Private Collaboration

The Innovative Medicines Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry. Born of the necessity to foster collaboration between different stakeholders in order to address growing challenges in bringing new medicines to market and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Laverty, Hugh, Meulien, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902875/
https://www.ncbi.nlm.nih.gov/pubmed/31850354
http://dx.doi.org/10.3389/fmed.2019.00275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902875/
https://www.ncbi.nlm.nih.gov/pubmed/31850354
http://dx.doi.org/10.3389/fmed.2019.00275

Ejemplares similares